Is Disease Severity Greater Among Patients with Rheumatoid Arthritis Who Receive a Newly Approved Biologic? Real-world US Experience with Sarilumab from the ACR RISE Registry

被引：0
|
作者：
Fiore, Stefano [1 ]
Chen, Lang [2 ]
Clinton, Cassie [2 ]
Yun, Huifeng [2 ]
Praestgaard, Amy [3 ]
Ford, Kerri [3 ]
Curtis, Jeffrey R. [2 ]
机构：
[1] Sanofi, Bridgewater, NJ USA
[2] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[3] Sanofi, Cambridge, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0834
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Patients in the Pompe registry who switched from alglucosidase alfa to avalglucosidase alfa: Real-world experience
    Schoser, B.
    Toscano, A.
    Foster, M.
    Periquet, M.
    Sparks, S.
    Kishnani, P.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S152 - S152
  • [32] Patients in the Pompe Registry who switched from alglucosidase alfa to avalglucosidase alfa: Real-world experience
    Schoser, B.
    Abbott, M.
    Toscano, A.
    Foster, M.
    Periquet, M.
    Sparks, S.
    Kishnani, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 572 - 573
  • [33] Real-World Evidence: Clinical and Economic Burden of Anemia, Venous Thromboembolism, and Malignancy Among Rheumatoid Arthritis Patients Switching from First Biologic DMARD to Another Treatment in the US
    Dore, Robin
    Antonova, Jenya
    Gorritz, Magdaliz
    Chang, Lawrence
    He, Jing
    Genovese, Mark
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [34] Real-World Use of Apremilast in Combination with Biologic Therapy in Patients with Psoriatic Arthritis: Findings from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
    Ogdie, Alexis
    Liu, Mei
    Glynn, Meghan
    Emeanuru, Kelechi
    Harrold, Leslie
    Richter, Sven
    Guerette, Benoit
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [35] Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry
    Weaver, AL
    Lautzenheiser, RL
    Schiff, MH
    Gibofsky, A
    Perruquet, JL
    Luetkemeyer, J
    Paulus, HE
    Xia, HA
    Leff, JA
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (01) : 185 - 198
  • [36] HIGH UNMET NEED AMONG RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO BIOLOGIC DMARD: REAL-WORLD ANALYSIS OF 2012-2016 US MEDICARE DATA
    Dore, Robin K.
    Antonova, Jenya
    Guo, Haifeng
    Li Suying
    Ozbay, Burak
    Genovese, Mark C.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1640 - 1640
  • [37] Real-World Use and Effectiveness Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: An Analysis from the CorEvitas Registry
    Joshua F. Baker
    Patrick Zueger
    Mira Ali
    Denise Bennett
    Miao Yu
    Yolanda Munoz Maldonado
    Robert R. McLean
    Rheumatology and Therapy, 2024, 11 : 363 - 380
  • [38] Real-World Consistency of Response to Adalimumab over Time in Patients with Rheumatoid Arthritis: Results from the Corrona Registry
    Pappas, Dimitrios A.
    Reed, George W.
    Karki, Chitra
    Griffith, Jenny
    Skup, Martha
    Garg, Vishvas
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [39] Real-World Use and Effectiveness Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: An Analysis from the CorEvitas Registry
    Baker, Joshua F.
    Zueger, Patrick
    Ali, Mira
    Bennett, Denise
    Yu, Miao
    Maldonado, Yolanda Munoz
    McLean, Robert R.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (02) : 363 - 380
  • [40] REAL-WORLD INTERRUPTIONS IN JANUS KINASE INHIBITOR THERAPY OBSERVED AMONG BIOLOGICNAIVE AND BIOLOGIC-EXPERIENCED RHEUMATOID ARTHRITIS PATIENTS
    Chastek, B.
    Koep, E.
    Mallya, U. G.
    Cockerham, A.
    Choi, J.
    Boklage, S.
    Furst, D. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 949 - 950
12345